COVID-19 vaccine success enables a bolder vision for mRNA cancer vaccines, says BioNTech CEO

Nature Reviews Drug Discovery
Volume 20 Issue 7, July 2021
https://www.nature.com/nrd/volumes/20/issues/7

 

An Audience With
COVID-19 vaccine success enables a bolder vision for mRNA cancer vaccines, says BioNTech CEO
Uğur Şahin, an oncologist and mRNA pioneer, discusses his firm’s development plans for cancer vaccines, mRNA-encoded proteins and more.
Asher Mullard